Huseyin Kacmaz
Overview
Explore the profile of Huseyin Kacmaz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
103
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ebik B, Bacaksiz F, Uzel A, Akkuzu M, Yavuz A, Kacmaz H, et al.
Rev Assoc Med Bras (1992)
. 2024 May;
70(4):e20231120.
PMID: 38716937
Objective: We aimed to examine the effect of remission status on thiol-disulfide homeostasis in celiac patients and thus to indirectly determine the effect of oxidative stress and inflammation caused by...
2.
Marasco G, Cremon C, Barbaro M, Cacciari G, Falangone F, Kagramanova A, et al.
Gut
. 2023 Jan;
PMID: 36591612
Objectives: The long-term consequences of COVID-19 infection on the gastrointestinal tract remain unclear. Here, we aimed to evaluate the prevalence of gastrointestinal symptoms and post-COVID-19 disorders of gut-brain interaction after...
3.
Ebik B, Kacmaz H, Tuncel E, Arpa M, Ucmak F, Kaya M
J Coll Physicians Surg Pak
. 2022 Oct;
32(10):1272-1277.
PMID: 36205270
Objective: To determine the factors affecting the procalcitonin level, and its association with the severity of pancreatitis in patients with acute pancreatitis (AP). Study Design: Cross-sectional analytical study. Place And...
4.
Ebik B, Aygan M, Tuncel E, Kacmaz H, Ekin N, Arpa M, et al.
Hepatol Forum
. 2022 Sep;
3(3):82-87.
PMID: 36177099
Background And Aim: Several studies have suggested that treatment with direct-acting antivirals (DAAs) in patients with chronic hepatitis C virus (HCV) may be associated with an increased risk of developing...
5.
Efe C, Lammert C, Tascilar K, Dhanasekaran R, Ebik B, Higuera-De La Tijera F, et al.
Liver Int
. 2021 Nov;
42(3):607-614.
PMID: 34846800
Background: We investigated associations between baseline use of immunosuppressive drugs and severity of Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis (AIH). Patients And Methods: Data of AIH patients with laboratory...
6.
Marasco G, Cremon C, Barbaro M, Salvi D, Cacciari G, Kagramanova A, et al.
Am J Gastroenterol
. 2021 Nov;
117(1):147-157.
PMID: 34751672
Introduction: Gastrointestinal (GI) symptoms in coronavirus-19 disease (COVID-19) have been reported with great variability and without standardization. In hospitalized patients, we aimed to evaluate the prevalence of GI symptoms, factors...
7.
Corapli M, Cil E, Oktay C, Kacmaz H, Corapli G, Bulut H
Clin Imaging
. 2021 Jul;
80:1-5.
PMID: 34214871
Purpose: To measure the degree of fatty liver using non-contrast enhanced chest computed tomography (CT) and investigate its relationship with the severity and prognosis of coronavirus disease 2019 (COVID-19) in...
8.
Efe C, Dhanasekaran R, Lammert C, Ebik B, Higuera-De La Tijera F, Aloman C, et al.
Hepatology
. 2021 Mar;
73(6):2099-2109.
PMID: 33713486
Background And Aims: Data regarding outcome of COVID-19 in patients with autoimmune hepatitis (AIH) are lacking. Approach And Results: We performed a retrospective study on patients with AIH and COVID-19...